메뉴 건너뛰기
Alimentary Pharmacology and Therapeutics
Volumn 39, Issue 11, 2014, Pages 1334-1335
Commentary: Probing probiotics in cirrhosis - A template for future studies?
Author keywords

[No Author keywords available]
Indexed keywords

PROBIOTIC AGENT;
EID: 84900003261     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.12751     Document Type: Note
Times cited : (2)
References (9)
  • 1
    • 0000606458 scopus 로고
    • The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances
    • Phillips GB, Schwartz R, Gabuzda GJ Jr, Davidson CS,. The syndrome of impending hepatic coma in patients with cirrhosis of the liver given certain nitrogenous substances. N Engl J Med 1952; 247: 239-46.
    • (1952) N Engl J Med , vol.247 , pp. 239-246
    • Phillips, G.B.1    Schwartz, R.2    Gabuzda, Jr.G.J.3    Davidson, C.S.4
  • 2
    • 84876283537 scopus 로고    scopus 로고
    • The gut microbiota and the liver. Pathophysiological and clinical implications
    • Quigley EM, Stanton C, Murphy EF,. The gut microbiota and the liver. Pathophysiological and clinical implications. J Hepatol 2013; 58: 1020-7.
    • (2013) J Hepatol , vol.58 , pp. 1020-1027
    • Quigley, E.M.1    Stanton, C.2    Murphy, E.F.3
  • 3
    • 84861990759 scopus 로고    scopus 로고
    • Techniques used to characterise the intestinal microbiota: A guide for the clinician
    • Fraher MH, O'Toole PW, Quigley EMM,. Techniques used to characterise the intestinal microbiota: a guide for the clinician. Nat Rev Gastroenterol 2012; 9: 312-22.
    • (2012) Nat Rev Gastroenterol , vol.9 , pp. 312-322
    • Fraher, M.H.1    O'Toole, P.W.2    Quigley, E.M.M.3
  • 5
    • 84875670330 scopus 로고    scopus 로고
    • Modulation of the metabolome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy
    • Bajaj JS, Heumann DM, Sanyal AJ, et al,. Modulation of the metabolome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy. PLoS ONE 2013; 8: e60042.
    • (2013) PLoS ONE , vol.8
    • Bajaj, J.S.1    Heumann, D.M.2    Sanyal, A.J.3
  • 6
    • 84899046306 scopus 로고    scopus 로고
    • Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis
    • Bajaj JS, Heuman DM, Hylemon PB, et al,. Randomised clinical trial: Lactobacillus GG modulates gut microbiome, metabolome and endotoxemia in patients with cirrhosis. Aliment Pharmacol Ther 2014; 39: 1113-25.
    • (2014) Aliment Pharmacol Ther , vol.39 , pp. 1113-1125
    • Bajaj, J.S.1    Heuman, D.M.2    Hylemon, P.B.3
  • 7
    • 39449089584 scopus 로고    scopus 로고
    • Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial
    • Dutch Acute Pancreatitis Study Group.
    • Besselink MG, van Santvoort HC, Buskens E, et al,., Dutch Acute Pancreatitis Study Group. Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 651-9.
    • (2008) Lancet , vol.371 , pp. 651-659
    • Besselink, M.G.1    Van Santvoort, H.C.2    Buskens, E.3
  • 8
    • 77949300275 scopus 로고    scopus 로고
    • Expression of concern-Probiotic prophylaxis in predicted severe acute pancreatitis: A randomised, double-blind, placebo-controlled trial
    • Expression of concern-Probiotic prophylaxis in predicted severe acute pancreatitis: a randomised, double-blind, placebo-controlled trial. Lancet 2010; 375: 875-6.
    • (2010) Lancet , vol.375 , pp. 875-876
  • 9
    • 77950491046 scopus 로고    scopus 로고
    • The PROPATRIA trial: Best practices at the time were followed
    • Dutch Pancreatitis Study Group.
    • Gooszen HG, Dutch Pancreatitis Study Group. The PROPATRIA trial: best practices at the time were followed. Lancet 2010; 375: 1249-50.
    • (2010) Lancet , vol.375 , pp. 1249-1250
    • Gooszen, H.G.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.